Data needed for haemochromatosis screening:
This article was originally published in Clinica
Executive Summary
Screening for hereditary haemochromatosis should not be introduced until there is good data available to show the extent of associated morbidity, says an editorial in the August 28 issue of the British Medical Journal. However, doctors should be made aware that disease prevalence is more common than previously thought, occurring in as many as five in every 1,000 white people of north European heritage, say the authors.